OPC Pharmaceutical JSC (HOSE:OPC)
Vietnam flag Vietnam · Delayed Price · Currency is VND
21,200
+200 (0.95%)
At close: Aug 13, 2026

OPC Pharmaceutical JSC Balance Sheet

Millions VND. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
243,321222,426175,594294,27486,591199,564
Short-Term Investments
81,00096,67471,62427,01869,34518,516
Trading Asset Securities
68.9568.9568.9568.95159,26968.95
Cash & Short-Term Investments
324,390319,169247,287321,361315,205218,148
Cash Growth
19.28%29.07%-23.05%1.95%44.49%142.82%
Accounts Receivable
278,731291,448250,721219,136162,534126,704
Other Receivables
-30,3376,0663,1641,1632,757782.12
Receivables
248,395297,514253,885220,299165,291127,486
Inventory
437,486410,293383,110358,590410,551522,621
Prepaid Expenses
6,4181,9971,1261,029555.45380.34
Other Current Assets
18,67322,44118,42726,39119,65517,690
Total Current Assets
1,035,3621,051,414903,835927,671911,258886,325
Property, Plant & Equipment
162,172162,516160,436171,073176,583190,985
Long-Term Investments
20,14221,28424,99624,38524,20323,688
Other Intangible Assets
72,16872,79373,94573,92875,03176,131
Long-Term Deferred Tax Assets
5,7746,0644,5599,5233,1553,305
Other Long-Term Assets
55,94157,62453,80154,24155,99457,766
Total Assets
1,351,5591,371,6951,221,5721,260,8211,246,2251,238,201

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
42,91761,25664,03443,67051,68571,055
Accrued Expenses
66,590102,77350,41782,89592,01693,386
Short-Term Debt
-----71,337
Current Income Taxes Payable
-13,63610,33215,64512,25412,496
Current Unearned Revenue
2,537--3,26228.45186.75
Other Current Liabilities
264,757209,109215,185226,274212,853241,172
Total Current Liabilities
376,801386,775339,969371,747368,836489,633
Long-Term Unearned Revenue
5,0005,000----
Other Long-Term Liabilities
4,4344,4124,7854,9115,4245,545
Total Liabilities
386,235396,187344,754376,657374,260495,177

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
640,509640,509640,509640,509640,509265,773
Additional Paid-In Capital
880.7880.7880.7880.7880.716,681
Retained Earnings
149,880268,404170,819180,558168,443398,705
Comprehensive Income & Other
109,451564.81----
Total Common Equity
900,720910,358812,208821,948809,833681,158
Minority Interest
64,60465,15064,61062,21662,13161,865
Shareholders' Equity
965,324975,508876,818884,164871,964743,023
Total Liabilities & Equity
1,351,5591,371,6951,221,5721,260,8211,246,2251,238,201

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-----71,337
Net Cash (Debt)
324,390319,169247,287321,361315,205146,811
Net Cash Growth
19.28%29.07%-23.05%1.95%114.70%1007.84%
Net Cash Per Share
4393.404259.023299.824288.274206.131959.07
Filing Date Shares Outstanding
70.5274.9474.9474.9474.9474.94
Total Common Shares Outstanding
70.5274.9474.9474.9474.9474.94
Working Capital
658,561664,638563,866555,924542,422396,693
Book Value Per Share
12771.7112147.9010838.1810968.1410806.489089.39
Tangible Book Value
828,552837,565738,264748,020734,802605,027
Tangible Book Value Per Share
11748.4011176.549851.459981.649805.268073.49
Buildings
-303,360301,197298,115294,247292,887
Machinery
-267,089259,564259,681251,688249,240
Construction In Progress
46,23637,17024,28821,63917,07914,351